Full video transcriptClick to expand
Auto-generated transcript of @alpha_tonton's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00For our advisors, we will use the number ofktors that will be possible,
- 0:03because we need to transfer from the maintainers,
- 0:06and we need to transfer from the maintenance application
- 0:08to the PayPal stream and the service in the future.
- 0:11So we need to transfer the $1,500.
- 0:13And we need to transfer it from the financial platform
- 0:15to the financial platform.
- 0:17And we need to transfer to the financial form,
- 0:20which can help us for the best way that to get which effect we do.
- 0:24So we really want to invest in our private sector,
- 0:27But, I'd like to ask you, the show
- 0:38is brought to you.
- 0:42Thank you.
- 0:45I'd like to ask you, as long as you can.
- 0:51is safe as you can see here.
- 0:53But you can find yourself at home in the corner of South Africa,
- 0:56which is very good.
- 0:58It's like a dress.
- 0:58It's like a dress.
- 0:58It's very good.
- 1:00And now we've got a lot of other ways to stay home.
- 1:02In the end, we'll see that you have a good weight.
- 1:05I'll make some fresh weights.
- 1:06You can really keep the weight down.
- 1:08I'll show you how to work.
- 1:09So these are professional sets that make beautiful shoes.
- 1:13So you can make them easy, with yourrections,
- 1:15with your feet, and your feet.
- 1:17You can lace them in each other and get it done,
- 1:21plus the
- 1:51and have a great day.
Subcutaneous vs intramuscular testosterone: what the data says
Quick answer
The video caption addresses a clinically relevant question in TRT practice: whether subcutaneous testosterone injection is as effective and safe as intramuscular administration. The actual transcript content does not address this topic in any coherent way, providing no clinical information viewers could act on. For patients self-administering testosterone, injection route selection affects absorption kinetics, hormone level stability, and injection site safety, all of which should be guided by a licensed prescriber.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 3 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Subcutaneous vs intramuscular testosterone: what the data says, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
Comparison decision path
Use this comparison to narrow the provider review question
Direct answer
Subcutaneous vs intramuscular testosterone: what the data says should help you decide which option deserves a clinical review, not force a one-size answer.
Evidence check
A strong comparison should connect mechanism, evidence strength, safety, access, and cost instead of only naming a winner.
Safety check
The right choice can change based on history, medication interactions, side effects, budget, and availability.
Next step
After comparing, use the get-started flow to route your goals and health history into the right prescription review path.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "Subcutaneous vs intramuscular testosterone: what the data says" from Tonton Alpha 🫡. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The video caption addresses a clinically relevant question in TRT practice: whether subcutaneous testosterone injection is as effective and safe as intramuscular administration.
The reason this review is not generic is the source wording and the canonical claim label "trt r ponse niko mouk quels sont les avantages de faire une inje." In this clip, the useful excerpt is: "For our advisors, we will use the number ofktors that will be possible, because we need to transfer from the maintainers, and we need to transfer from the maintenance application to the PayPal stream and the service in the future." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
The video caption addresses a clinically relevant question in TRT practice: whether subcutaneous testosterone injection is as effective and safe as intramuscular administration.
FormBlends verdict
Testosterone evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The video caption addresses a clinically relevant question in TRT practice: whether subcutaneous testosterone injection is as effective and safe as intramuscular administration. The actual transcript content does not address this topic in any coherent way, providing no clinical information viewers could act on. For patients self-administering testosterone, injection route selection affects absorption kinetics, hormone level stability, and injection site safety, all of which should be guided by a licensed prescriber.
- Spratt et al. (2017, JCEM) found SC testosterone cypionate produced stable serum levels comparable to IM, with less peak-to-trough variability in studied patients.
- SC injections typically use 27-29 gauge needles versus 21-23 gauge for IM, which contributes to lower self-reported injection discomfort in patient preference studies.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Spratt et al. (2017, JCEM) found SC testosterone cypionate produced stable serum levels comparable to IM, with less peak-to-trough variability in studied patients.
- SC injections typically use 27-29 gauge needles versus 21-23 gauge for IM, which contributes to lower self-reported injection discomfort in patient preference studies.
- Kaminetsky et al. (2019) reported higher patient satisfaction with SC self-injection compared to IM among TRT patients in an outpatient setting.
- Repeated SC injections at the same site can cause lipodystrophy over time. Rotating injection sites is standard practice to reduce this risk.
- The Endocrine Society 2018 clinical practice guidelines acknowledge SC testosterone as an acceptable administration route, though IM remains more historically common in clinical settings.
- SC is often paired with more frequent dosing such as twice weekly to maintain stable levels. IM is more commonly given weekly or every two weeks depending on the ester.
- This video's transcript contained no information about its stated topic. Viewers seeking SC versus IM guidance from this content would receive none.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @alpha_tonton actually say?
Honestly? Very little that's usable. The transcript provided for this video is incoherent, referencing PayPal transfers, shoes, and South Africa rather than anything related to subcutaneous versus intramuscular testosterone injections. The caption promises a comparison of injection routes for what appears to be a TRT-related audience, but the actual spoken content doesn't deliver that. We can't fact-check claims that weren't made, so we'll use this space to address what the video claimed it would cover based on its caption and stated question.
The caption asks three specific things: what are the advantages of subcutaneous over intramuscular injection, whether they're equally effective, and whether there are risks. These are legitimate clinical questions worth answering properly, even if this video apparently didn't answer them at all.
Does the science back up the premise?
The premise, that SC and IM routes are worth comparing for testosterone administration, is well-supported. The question is no longer fringe. It's been studied directly.
A 2017 study by Spratt et al. published in the Journal of Clinical Endocrinology and Metabolism found that subcutaneous testosterone cypionate injections produced stable serum testosterone levels comparable to intramuscular administration, with less variability in peak-to-trough swings. That variability point matters clinically. Large peaks and troughs with IM injections have been associated with mood fluctuation and erythrocytosis risk in some patients.
A 2019 analysis by Kaminetsky et al. in the Journal of Drugs in Dermatology further supported SC administration as a viable route, noting patient preference for self-injection was higher with SC due to reduced injection-site discomfort. Needles used for SC are shorter and thinner, typically 27-29 gauge, compared to the 21-23 gauge needles often used for deep IM injections.
So the premise of the comparison is scientifically grounded. The video just apparently didn't get there.
What did they get wrong, or right?
There is nothing to fact-check in the actual transcript. The audio content has no relationship to the stated topic. This is a significant problem for any viewer who watched expecting clinical guidance on injection technique and instead got an incoherent monologue. That's not a minor slip. For a topic like injection administration, which carries real procedural risk if done incorrectly, uninformative content dressed up as expert guidance is a problem.
What the video got right, structurally, is asking questions that matter to TRT patients. SC versus IM is a genuinely debated topic in clinical practice. Many endocrinologists and urologists still default to IM out of habit rather than evidence, so raising the question has value. The failure is in not answering it.
- No evidence that SC is discussed or explained
- No evidence that IM risks are addressed
- No evidence that efficacy comparison was made
- Transcript content is entirely unrelated to the stated topic
What should you actually know?
If you're on TRT or considering it, here is what the actual evidence says about injection routes. SC injections into abdominal or thigh fat deposits are generally well-tolerated and produce slower, more stable absorption. This can translate to more consistent hormone levels week to week. IM injections, typically into the gluteus or vastus lateralis, are absorbed faster and can produce higher initial peaks followed by a more rapid decline.
Neither route is universally superior. Patient body composition matters, very lean individuals may have limited SC tissue. Injection frequency also matters: SC is often used with more frequent, smaller doses such as twice weekly, which helps flatten the curve further.
Risks exist with both routes. Improper SC technique can cause lipodystrophy or localized fat changes at the injection site over time. IM injections carry risk of hitting a nerve or blood vessel if technique is poor. Neither risk is common when done correctly, but neither is zero.
Always discuss route selection with a licensed prescribing clinician. FormBlends providers can assess which approach fits your specific protocol and body composition.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Tonton Alpha 🫡 · TikTok creator
51.4K views on this video
Réponse à @Niko mouk Quels sont les avantages de faire une injection en sous cutanée vs intra musculaire ? Est ce que c’est aussi efficace ? Y’a t-il des risques ? #bodybuilding #bodybuilder #workout #workouttips
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about spratt et al. (2017, jcem) found sc testosterone cypionate produced?
Spratt et al. (2017, JCEM) found SC testosterone cypionate produced stable serum levels comparable to IM, with less peak-to-trough variability in studied patients.
What does the video say about sc injections typically use 27-29 gauge needles versus 21-23 gauge?
SC injections typically use 27-29 gauge needles versus 21-23 gauge for IM, which contributes to lower self-reported injection discomfort in patient preference studies.
What does the video say about kaminetsky et al. (2019) reported higher patient satisfaction with sc?
Kaminetsky et al. (2019) reported higher patient satisfaction with SC self-injection compared to IM among TRT patients in an outpatient setting.
What does the video say about repeated sc injections at the same site can cause lipodystrophy?
Repeated SC injections at the same site can cause lipodystrophy over time. Rotating injection sites is standard practice to reduce this risk.
What does the video say about the endocrine society 2018 clinical practice guidelines acknowledge sc testosterone?
The Endocrine Society 2018 clinical practice guidelines acknowledge SC testosterone as an acceptable administration route, though IM remains more historically common in clinical settings.
What does the video say about sc?
SC is often paired with more frequent dosing such as twice weekly to maintain stable levels. IM is more commonly given weekly or every two weeks depending on the ester.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Tonton Alpha 🫡, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.